A Study of the Efficacy, Safety, and Pharmacokinetics (PK) of the Port Delivery System With Ranibizumab (PDS) in Chinese Participants With Neovascular Age-related Macular Degeneration (nAMD)

Peking Union Medical College Hospital, Beijing, China

Beijing Hospital, Beijing, China

Beijing Tongren Hospital, Beijing, China

West China Hospital, Sichuan University, Chengdu, China

Sichuan Provincial People's Hospital, Chengdu, China

Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou, China

The Second Affiliated Hospital of Harbin Medical University, Harbin, China

Qingdao Eye Hospital of Shandong First Medical University, Qingdao, China

Shanghai First People's Hospital, Shanghai, China

Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China

The First Affiliated Hospital of China Medical University, Shenyang, China

Shanxi Eye Hospital, Taiyuan, China

Tianjin Medical University Eye Hospital, Tianjin, China

Eye Hospital, Wenzhou Medical University, Wenzhou, China

Tongji Hospital Tongji Medical College Huazhong University of Science and Technology, Wuhan, China

Xi'an People's Hospital (Xi'an Fourth Hospital), Xi'an, China